angiotensin ii, des-phe(8)- has been researched along with glycolipids in 1 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (glycolipids) | Trials (glycolipids) | Recent Studies (post-2010) (glycolipids) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 19,062 | 170 | 5,050 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Liu, JY; Shi, TT; Song, LN; Xin, Z; Yang, JK; Zhang, YC | 1 |
1 other study(ies) available for angiotensin ii, des-phe(8)- and glycolipids
| Article | Year |
|---|---|
Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cell Line, Tumor; Down-Regulation; Glycolipids; Hep G2 Cells; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria; Non-alcoholic Fatty Liver Disease; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2020 |